BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9357432)

  • 1. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
    Nelson RR
    Lancet; 1997 Nov; 350(9087):1327. PubMed ID: 9357432
    [No Abstract]   [Full Text] [Related]  

  • 2. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities.
    Michel M; Gutmann L
    Lancet; 1997 Jun; 349(9069):1901-6. PubMed ID: 9217771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus in hospitalized children.
    Fisher MC
    Pediatr Infect Dis J; 1998 Sep; 17(9):825-6. PubMed ID: 9779772
    [No Abstract]   [Full Text] [Related]  

  • 4. Nosocomial methicillin--resistant Staphylococcus aureus with reduced susceptibility to vancomycin.
    Bhat G; Kamath S; Hussain A
    Indian J Pathol Microbiol; 2006 Apr; 49(2):311-2. PubMed ID: 16933753
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduced susceptibility of Staphylococcus aureus to vancomycin--Japan, 1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Jul; 46(27):624-6. PubMed ID: 9218648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Infections of vancomycin resistant enterococci (VRE) and Staphylococcus aureus (VRSA)].
    Kuwahara K; Hanaki H; Hiramatsu K
    Ryoikibetsu Shokogun Shirizu; 1999; (23 Pt 1):182-5. PubMed ID: 10088368
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy and safety of tigecycline compared with vancomycin or linezolid for treatment of serious infections with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci: a Phase 3, multicentre, double-blind, randomized study.
    Florescu I; Beuran M; Dimov R; Razbadauskas A; Bochan M; Fichev G; Dukart G; Babinchak T; Cooper CA; Ellis-Grosse EJ; Dartois N; Gandjini H;
    J Antimicrob Chemother; 2008 Sep; 62 Suppl 1():i17-28. PubMed ID: 18684703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enemy within. Basic weapons can foil VRE (vancomycin-resistant enterococcus).
    Pugliese G
    Mater Manag Health Care; 1997 Sep; 6(9):32, 34, 36-8. PubMed ID: 10173223
    [No Abstract]   [Full Text] [Related]  

  • 9. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci.
    Humphreys H; Keane CT
    Lancet; 1997 Sep; 350(9079):737-8. PubMed ID: 9291923
    [No Abstract]   [Full Text] [Related]  

  • 10. Vancomycin resistance in gram-positive cocci.
    Courvalin P
    Clin Infect Dis; 2006 Jan; 42 Suppl 1():S25-34. PubMed ID: 16323116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of the in vitro activity of 2 glycopeptides (vancomycin and teicoplanin) against methicillin-resistant Staphylococcus aureus of intrahospital origin].
    Gil M; Otth L; Wilson M; Arce E; Zaror A; Lizama V
    Rev Med Chil; 2000 Jan; 128(1):111-2. PubMed ID: 10883531
    [No Abstract]   [Full Text] [Related]  

  • 12. Vancomycin-resistant enterococci.
    Thakor K; Glatt AE
    Clin Podiatr Med Surg; 1996 Oct; 13(4):661-9. PubMed ID: 8902337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Seeking vancomycin resistant Staphylococcus aureus among patients with vancomycin-resistant enterococci.
    Franchi D; Climo MW; Wong AH; Edmond MB; Wenzel RP
    Clin Infect Dis; 1999 Dec; 29(6):1566-8. PubMed ID: 10585815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methicillin-resistant Staphylococcus aureus pneumonia treatment: do not confuse pharmacokinetics and pharmacodynamics.
    Moine P; Bédos JP
    Chest; 2007 Sep; 132(3):1101, author reply 1102-3. PubMed ID: 17873216
    [No Abstract]   [Full Text] [Related]  

  • 15. Novel semi-synthetic glycopeptide antibiotics active against methicillin-resistant staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE): doubly-modified water-soluble derivatives of chloroorienticin B.
    Yoshida O; Yasukata T; Sumino Y; Munekage T; Narukawa Y; Nishitani Y
    Bioorg Med Chem Lett; 2002 Nov; 12(21):3027-31. PubMed ID: 12372494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: Antibiotics and periodontal disease.
    Gillette W
    J Periodontol; 1996 Jul; 67(7):726. PubMed ID: 8832485
    [No Abstract]   [Full Text] [Related]  

  • 17. [Conjugative transfer of glycopeptide and macrolide resistant genes among Enterococci and from Enterococcus faecalis to Staphylococcus aureus].
    Młynarczyk A; Młynarczyk G; Łuczak M
    Med Dosw Mikrobiol; 2002; 54(1):21-8. PubMed ID: 12185680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin-resistant enterococci; the ultimate nosocomial pathogen?
    Mahon CR; Bowman S
    Clin Lab Sci; 1998; 11(3):133-6. PubMed ID: 10181154
    [No Abstract]   [Full Text] [Related]  

  • 19. Emerging resistance in Enterococcus spp.
    Heath CH; Blackmore TK; Gordon DL
    Med J Aust; 1996 Jan; 164(2):116-20. PubMed ID: 8569563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vancomycin-resistant Staphylococcus aureus: apocalypse now?
    Tabaqchali S
    Lancet; 1997 Dec; 350(9092):1644-5. PubMed ID: 9400504
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.